STACY NEWBERRY: Open Payments
NPI 1841775947 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,505 in 42 payments from 8 companies in 2025. Trend: 2023 $5,494 · 2024 $5,993 · 2025 $15,505
Speaker / faculty: $11,900Travel & lodging: $2,379Food & beverage: $1,196Education: $31
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 23 | $11,005 |
| Daiichi Sankyo Inc. | 10 | $4,220 |
| Janssen Biotech, Inc. | 1 | $114 |
| PFIZER INC. | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| ABBVIE INC. | 2 | $29 |
| Incyte Corporation | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: DATROWAY, IMFINZI, TECVAYLI, IBRANCE, LUTATHERA, MONJUVI, SCEMBLIX, ELREXFIO.
Industry payments across OK — which companies pay providers there.
